Earlier this year Haemochromatosis UK announced plans to expand their senior management team by appointing a new Chief Executive and creating an Operations Executive role to be taken up by David Head, the existing Chief Executive.
The trustees are delighted to confirm that the selection process is complete, with our new Chief Executive now joining us part-time in June and taking up the post full-time from 01 July. The new appointee will be introduced to our members as soon as we are able to complete the formalities.
Corrina Towers, Chair at HUK, said “The process of recruiting our new Chief Executive has been the most important decision we have had to make this year. We are looking forward to welcoming him formally and are excited to have him lead the next important phase of our development as a patient body with growing influence and a greater capacity to support people affected by GH.”